• Es befinden sich keine Produkte im Warenkorb.

  • LOGIN

Literatur und weiterführende Links (FOOD 16-17)

Literaturliste

Abrams SA, Wen J, Stuff JE: Absorption of calcium, zinc, and iron from breast milk by five- to seven-month-old infants. Pediatr Res1997; 41: 384–390.

Abrams SA: Nutritional rickets: an old disease returns. Nutr Rev 2002; 60: 111-115.

Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998; 158:917.

Ahlborg HG, Johnell O, Turner CH et al.: Bone loss and bone size after meno pause. N Engl J Med 2003; 349: 327-334.

Aikawa JK. Magnesium: Its Biological Significance. Boca Raton, FL: CRC Press; 1981.

Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002; 359 (9321): 1877–1890.

Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects. Magnesium 1985; 4: 226–244.

American Academy of Pediatrics: Breastfeeding and the use of human milk. Pediatrics 129, 2012, e827-e841.

Ames SK, Gorham BM, Abrams SA: Effects of high compared with low calcium intake on calcium absorption and incorporation of iron by red blood cells in small children. Am J Clin Nutr 1999; 70: 44‑48.

Aslam S, Friedman EA, Ifudu O. Electrocardiography is unreliable in detecting potentially lethal hyperkalaemia in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 1639.

Atalar E, Aydin G, Keles I et al.: Factors affecting bone mineral density in men. Rheumatol Int 2009; 29: 1025-1030.

Barger-Lux MJ, Davies KM, Heaney RP: Calcium supplementation does not augment bone gain in young women consuming diets moderately low in calcium. J Nutr 2005; 135: 2362-2366.

Barnes BA, Cope O, Harrison T. Magnesium conservation in the human being on a low magnesium diet. J Clin Invest 1958; 37: 430–440.

Bashour T, Hsu I, Gorfinkel HJ, et al. Atrioventricular and intraventricular conduction in hyperkalemia. Am J Cardiol 1975; 35: 199.

Belfort MA, Anthony J, Saade GR, Allen JC Jr, for the Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med. 2003; 348(4): 304–311.

Bergwitz C, Juppner H (2010) Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61: 91–104.

Berne RM, Levy MN. Cardiovascular Physiology, 4th Ed, Mosby, St Louis 1981.

Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002; 22(5): 345–353.

Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA et al.: Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 86 (2007): 1780-1790.

Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B et al.: Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 2009: 24: 935-942.

Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2005(4): CD003898.

Body JJ, Bergmann P, Boonen S et al.: Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporos Int 2012; 23, Suppl 1: S1-S23.

Bolland MJ, Barber PA, Doughty RN et al: Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008; 336: 262–266.

Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ. 2011 19; 342: d2040.

Brasier AR, Nussbaum SR (1988) Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 84(4): 654–660.

Broeren MA, Geerdink EA, Vader HL et al. Hypomagnesemia induced by several proton-pump inhibitors. Ann Intern Med 2009; 151: 755–756.

Camp MA, Allon M (1990) Severe hypophosphatemia in hospitalized patients. Miner Electrolyte Metab 16(6): 365–368.

Cashman KD: Calcium intake, calcium bioavailability and bone health. Br J Nutr 2002; 87, Suppl 2, S169-S177.

Chefetz I, Sprecher E (2009) Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis. Biochim Biophys Acta 1792(9): 847–852.

Chernow B, Bamberger S, Stoiko M et al. Hypomagnesemia in patients in postoperative intensive care. Chest 1989; 95: 391–397.

Cohen L, Laor A. Correlation between bone magnesium concentration and magnesium retention in the intravenous magnesium load test. Magnes Res 1990; 3: 271–274.

Cunningham J, Rodríguez JM, Messa P. Magnesium in chronic kidney disease stages 3 and 4, and in dialysis patients. Clin Kidney J 2012; 5 (Suppl 1): i39–i51.

D-A-CH (DGE, ÖGE, SGE, SVE) (Hrsg.), Referenzwerte für die Nährstoffzufuhr, 1. Auflage, Neuer Umschau Buchverlag, Neustadt, 2008.

de Baaij JHF, Hoenderop JGJ, Bindels RJM. Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J 2012; 5 (Suppl 1): i15–i24.

Dengel JL, Mangels AR, Moser-Veillon PB. Magnesium homeostasis: conservation mechanism in lactating women consuming a controlled-magnesium diet. Am J Clin Nutr. 1994; 59: 990-4.

Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (Hg): Referenzwerte für die Nährstoffzufuhr. Neuer Umschau Buchverlag, Neustadt a. d. Weinstraße, 1. Auflage, 3. korrigierter Nachdruck, 2008

Dionyssiotis Y, Paspati I, Trovas G et al.: Association of physical exercise and calcium intake with bone mass measured by quantitative ultrasound. BMC Women’s Health 2010; 10: 1-12.

Dirks JH. The kidney and magnesium regulation. Kidney Int 1983; 23: 771–777.

Duley L, Gülmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2003; (2): CD000025.

Duley L, Gulmezoglu AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev. 2001; (1): CD002960.

Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2003; (4): CD000128.

EFSA (European Food Safety Authority): Scientific opinion on the tolerable upper intake level of calcium. EFSA Journal 2012; 10: 2814.

Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010; 23: 194–198.

Elin RJ. Magnesium metabolism in health and disease. Dis Mon 1988; 34: 161–218.

Elliott C, Newman N, Madan A. Gentamicin effects on urinary electrolyte excretion in healthy subjects. Clin Pharmacol Ther 2000; 67: 16–21.

Evers S, Engelien A, Karsch V, Hund M. Secondary hyperkalaemic paralysis. J Neurol Neurosurg Psychiatry 1998; 64: 249.

Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999; 83: 302–320.

Fomon SJ, Nelson SE: Calcium, phosphorus, magnesium, and sulfur. In: Fomon SJ (Hrsg.): Nutrition of Normal Infants. Mosby, St. Louis, 1. Auflage, 1993, 192–218.

Freeman SJ, Fale AD. Muscular paralysis and ventilatory failure caused by hyperkalaemia. Br J Anaesth 1993; 70: 226.

Frohlich ED, Chien Y, Sesoko S, Pegram BL. Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats. Am J Physiol 1993; 264: R30–R34.

Fung MC, Weintraub M, Bowen DL. Hypermagnesemia. Elderly over-the-counter drug users at risk. Arch Fam Med 1995; 4: 718–723.

Galla JH, Booker BB, Luke RG. Role of the loop segment in the urinary concentrating defect of hypercalcemia. Kidney Int 1986; 29: 977–982.

Gallen IW, Rosa RM, Esparaz DY et al. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. Am J Kidney Dis 1998; 31: 19–27.

Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 2003; 17: 471–480.

Graham L, Caesar J, Burgen A. Gastrointestinal absorption and excretion of Mg28 in man. Metabolism 1960; 9: 646–659.

Grant AM, Avenell A, Campbell MK et al.; RECORD Trial Group: Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365: 1621-1628.

Green DM, Ropper AH, Kronmal RA, Psaty BM, Burke GL. Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology 2002; 59: 314–320.

Green J, Debby H, Lederer E et al (2001) Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia. Kidney Int 60(3): 1182–1196.

Greenberg A. Hyperkalemia: treatment options. Semin Nephrol 1998; 18:46.

Guéguen L, Pointillart A: The bioavailability of dietary calcium. J Am Coll Nutr 2000; 19, Suppl 2, S119-S136.

Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004; 30: 253–258.

Gullestad L, Midtvedt K, Dolva LO, Norseth J, Kjekshus J. The magnesium loading test: reference values in healthy subjects. Scand J Clin Lab Invest. 1994; 54: 23-31.

Hashizume N, Mori M. An analysis of hypermagnesemia and hypomagnesemia. Jpn J Med 1990; 29: 368–372.

Heaney RP, Recker RR: Distribution of calcium absorption in middle-aged women. Am J Clin Nutr 1986; 43: 299–305.

Heaney RP, Weaver CM: Newer perspectives on calcium nutrition and bone quality. J Am Coll Nutr 2005; 24, Suppl 6: S574-S581.

Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010; (8): CD001059.

Hoppe A, Metler M, Berndt TJ et al (1982) Effect of respiratory alkalosis on renal phosphate excretion. Am J Physiol 243 (5): F471–F475.

Hunt CD, Johnson LK: Calcium requirements: new estimations for men and women by crosssectional statistical analyses of calcium balance data from metabolic studies. Am J Clin Nutr 2007; 86: 1054‑1063.

IOM (Institute of Medicine): Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press, Washington DC, 2011, S205.

Jackman LA, Millane SS, Martin BR et al.: Calcium retention in relation to calcium intake and postmenarcheal age in adolescent females. Am J Clin Nutr 1997; 66: 327-333.

Jackson RD, LaCroix AZ, Gass M et al.: Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 16: 669-683.

June CH, Thompson CB, Kennedy MS et al. Correlation of hypomagnesemia with the onset of cyclosporine-associated hypertension in marrow transplant patients. Transplantation 1986; 41: 47–51.

Kamel KS, Wei C. Controversial issues in the treatment of hyperkalaemia. Nephrol Dial Transplant 2003; 18: 2215.

Kayne LH, Lee DB. Intestinal magnesium absorption. Miner Electrolyte Metab 1993; 19: 210–217.

Kebler R, McDonald FD, Cadnapaphornchai P (1985) Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am J Med 79 (5): 571–576.

Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med 1987; 316: 235–240.

Kontani M, Hara A, Ohta S et al. Hypermagnesemia induced by massive cathartic ingestion in an elderly woman without pre-existing renal dysfunction. Intern Med 2005; 44: 448–452.

Koopman R, van Loon LJ: Aging, exercise, and muscle protein metabolism. J Appl Physiol 2009;106: 2040-2048.

Krems C, Walter C, Heuer T, Hoffmann I: Lebensmittelverzehr und Nährstoffzufuhr – Ergebnisse der Nationalen Verzehrsstudie II. In: Deutsche Gesellschaft für Ernährung (Hrsg.): 12. Ernährungsbericht 2012. Bonn, 2012, S 40-85.

Kroll MH, Elin RJ. Relationships between magnesium and protein concentrations in serum. Clin Chem 1985; 31: 244–246.

Lajer H, Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev 1999; 25: 47–58.

Li K, Kaaks R, Linseisen J, Rohrmann S: Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 2012; 98: 920-925.

Lotz M, Zisman E, Bartter FC (1968) Evidence for a phosphorus-depletion syndrome in man. N Engl J Med 278 (8): 409–415.

Maguire ME, Cowan JA. Magnesium chemistry and biochemistry. Biometals 2002; 15: 203–210.

Marinella MA (2003) The refeeding syndrome and hypophosphatemia. Nutr Rev 61 (9): 320–323.

Massey LK, Roman-Smith H, Sutton RA: Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Diet Assoc 1993; 93: 901-906.

Massry SG, Seelig MS. Hypomagnesemia and hypermagnesemia. Clin Nephrol 1977; 7: 147–153.

Mattu A, Brady WJ, Robinson DA. Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med 2000; 18: 721.

Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache. 1995; 35 (10): 597–600.

Max-Rubner Institut zur Nationalen Verzehrstudie II verfügbar unter: https://www.mri.bund.de/de/institute/ernaehrungsverhalten/forschungsprojekte/nvsii/(eingesehen am 28.06.2022)

Michaëlsson K, Melhus H, Warensjö Lemming E et al.: Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 2013; 346 f 228.

Moe SM: Disorders involving calcium, phosphorus, and magnesium. Prim Care 2008; 35: 215-237.

Montague BT, Ouellette JR, Buller GK. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol 2008; 3: 324.

Mount DB, Zandi-Nejad K. Disorders of Potassium Balance. In: Brenner and Rector’s The Kidney, 9th Ed, WB Saunders & Company, Philadelphia 2011. p.640.

Murer H, Hernando N, Forster I, Biber J: Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 2000; 80: 1373–1409.

Nadler JL, Rude RK. Disorders of magnesium metabolism. Endocrinol Metab Clin North Am 1995; 24: 623–641.

Neville MC, Keller R, Seacat J et al.: Studies in human lactation: milk volumes in lactating women during the onset of lactation and full lactation. Am J Clin Nutr 1988; 48: 1375-1386.

NOF (National Osteoporosis Foundation): Clinician’s guide to prevention and treatment of osteoporosis. Washington DC, 2008.

Onalan O, Crystal E, Daoulah A, Lau C, Crystal A, Lashevsky I. Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation. Am J Cardiol. 2007;99 (12): 1726–1732.

Onishi S, Yoshino S. Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med 2006; 45: 207–210.

Paltiel O, Salakhov E, Ronen I et al. Management of severe hypokalemia in hospitalized patients: a study of quality of care based on computerized databases. Arch Intern Med 2001; 161: 1089–1095.

Peacock M, Liu G, Carey M et al.: Effect of calcium or 25-OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 2000; 85: 3011-3019.

Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010;5 Suppl 1: S23-30.

Peacock M: Calcium absorption efficiency and calcium requirements in children and adolescents. Am J Clin Nutr 1991; 54, Suppl 1: S261–S265.

Pettersson U, Nilsson M, Sundh V et al.: Physical activity is the strongest predictor of calcaneal peak bone mass in young Swedish men. Osteoporos Int 2010; 21: 447-455.

Pettifor JM, Fischer PR, Thacher TD: Dietary calcium deficiency and rickets. In: Holick MF (Hrsg.): Nutrition and Health: Vitamin D. Springer Science+Business Media, New York, 2. Auflage, 2010, 651-668.

Prince RL, Devine A, Dhaliwal SS, Dick IM: Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 2006; 166: 869-875.

Reis MA, Reyes FG, Saad MJ et al. Magnesium deficiency modulates the insulin signaling pathway in liver but not muscle of rats. J Nutr 2000; 130: 133–138.

Reungjui S, Hu H, Mu W et al. Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int 2007; 72: 1483–1492.

Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, Mc-Graw Hill, New York 2001. p.913.

Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev. 2000;( 2): CD001490.

Rude R. Magnesium disorders. In: Kokko J, Tannen R (eds). Fluids and electrolytes. Philadelphia, PA: W.B. Saunders Company, 1996, pp. 421–445.

Rude RK, Shils ME. Magnesium. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ. , eds. Modern Nutrition in Health and Disease. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005: 223–248.

Rude RK. Magnesium metabolism and deficiency. Endocrinol Metab Clin North Am 1993; 22: 377–395.

Ryan MP. Diuretics and potassium/magnesium depletion. Directions for treatment. Am J Med 1987; 82: 38–47.

Ryzen E,Wagers PW, Singer FR et al. Magnesium deficiency in a medical ICU population. Crit Care Med 1985; 13: 19–21.

Shaikh A, Berndt T, Kumar R (2008) Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr Nephrol 23 (8): 1203–1210.

Siani A, Strazzullo P, Giacco A, Pacioni D, Celentano E, Mancini M. Increasing the dietary potassium intake reduces the need for antihypertensive medication. Ann Intern Med 1991; 115: 753–759.

Souci SW, Fachmann W, Kraut H: Die Zusammensetzung der Lebensmittel. Nährwert-Tabellen. medpharm Scientific Publishers, Stuttgart, 7. Auflage, 2008.

Strain JJ, Cashman KD: Minerals and trace elements. In: Gibney MJ, Lanham-New SA, Cassidy A, Vorster HH (Hrsg.): Introduction to Human Nutrition. Wiley-Blackwell, Chichester, 2. Auflage, 2009, 188-237.

Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003; 24: 47–66.

Szerlip HM, Weiss J, Singer I. Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis 1986; 7: 461.

Taddei S, Mattei P, Virdis A, Sudano I, Ghiadoni L, Salvetti A. Effect of potassium on vasodilation to acetylcholine in essential hypertension. Hypertension 1994; 23: 485–490.

Tang BMP, Eslick GD, Nowson C et al.: Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a metaanalysis. Lancet 2007; 370: 657-666.

TB Drüeke, D Prié: Klotho spins the thread of life – what does Klotho do to the receptors of fibroblast growth factor-23 (FGF23)?. In: Nephrol Dial Transplant. Nr. 22 (6), 2007, S. 1524–1526.

Touyz RM. Magnesium in clinical medicine. Front Biosci 2004; 9: 1278–1293.

Tunstall-Pedoe H. Does dietary potassium lower blood pressure and protect against coronary heart disease and death? Findings from the Scottish Heart Health Study? Semin Nephrol 1999; 19: 500–50.

Uusi-Rasi K, Sievänen H, Pasanen M et al.: Influence of calcium intake and physical activity on proximal femur bone mass and structure among pre- and postmenopausal women. A 10-year prospective study. Calcif Tissue Int 2008; 82: 171-181.

Vatanparast H, Bailey DA, Baxter-Jones AD, Whiting SJ: Calcium requirements for bone growth in Canadian boys and girls during adolescence. Br J Nutr 2010; 103: 575-580.

Wacker W. Magnesium and Man. Cambridge, MA: Havard University Press; 1980; 1–184.

Wallace RB, Wactawski-Wende J, O’Sullivan MJ et al.: Urinary tract stone occurrence in the Women’s Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr 2011; 94: 270-277.

Walser M. Magnesium metabolism. Ergeb Physiol 1967; 59: 185–296.

Wang L, Manson JE, Song Y, Sesso HD: Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010; 152: 315-323.

Wang Q, Domenighetti AA, Pedrazzini T, Burnier M. Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice. Hypertension 2005; 46: 547–554.

Wazny LD, Brophy DF. Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia. Ann Pharmacother 2000; 34: 94–97.

WCRF (World Cancer Research Fund)/AICR (American Institute for Cancer Research): Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC; AICR, 2007.

Weaver C, Heaney R: Food sources, supplements, and bioavailability. In: Weaver C, Heaney R (Hrsg.): Calcium in Human Health. Humana Press, Totowa, 1. Auflage, 2006, 129-142.

Weaver CM, Heaney R: Calcium. In: Shils M, Shike M, Ross AC et al. (Hrsg.): Modern Nutrition in Health and Disease. Lippincott Williams & Wilkins, Baltimore, 10. Auflage, 2006, S 194-210.

Weaver CM, Hill KM: Estimating calcium requirements. In: Burckhardt P, Dawson-Hughes B, Weaver C (Hrsg.): Nutritional Influences on Bone Health. Springer, London, 1. Auflage, 2010, 41-50.

Weaver CM: Age related calcium requirements due to changes in absorption and utilization. J Nutr 1994; 124, Suppl 8, S1418-S1425.

Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA 1990; 263: 3063–3064.

Whelton PK, He J, Cutler JA et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997; 277: 1624–1632.

WHO (World Health Organization): Nutrient adequacy of exclusive breastfeeding for the term infant during the first six months of life. Authors: Butte NF, Lopez-Alarcon MG, Garza C, 2002. Verfügbar unter: http://www.who.int/nutrition/publications/infantfeeding/nut_adequacy_of_exc_bfeeding_eng.pdf (eingesehen am 28.06.2022)

Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol. 1998; 92 (5): 883–889.

Wolff I, van Croonenborg JJ, Kemper HC et al.: The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 1999; 9: 1-12.

Wong ET, Rude RK, Singer FR et al. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 1983; 79: 348–352.

Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med. 2013 22; 173: 639-46.

Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001; 44: 1201–1209.

Yáñez M, Gil-Longo J, Campos-Toimil M. Calcium binding proteins. Adv Exp Med Biol. 2012; 740: 461-82.

Kursübergreifende Literaturangaben zu Vitaminen und Spurenelementen

Biesalski HK, Biscoff SC, Puchstein C. Ernährungsmedizin. Nach dem neuen Curriculum Ernährungsmedizin der Bundesärztekammer. 4. Auflage. Georg Thieme Verlag, Stuttgart 2010

Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin. Toxikologische und ernährungsphysiologische Aspekte der Verwendung von Mineralstoffen und Vitaminen in Lebensmitteln. Teil I: Mineralstoffe (einschließlich Spurenelemente). Vorschläge für Regelungen und Höchstmengen zum Schutz des Verbrauchers vor Überdosierung beim Verzehr von Nahrungsergänzungsmitteln (NEM) und angereicherten Lebensmitteln. Januar 2002

Cliniguía. Actualización de diagnóstico y terapéutica. EviScience Publicaciones 2011

Colastra J: Lamberts. Manual de Nutrición Ortomolecular. El manual de consulta imprescindible. SIE Consultants sl 2010

D-A-CH (2000) Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungsforschung (SGE), Schweizerische Vereinigung für Ernährung (SVE): Referenzwerte für die Nährstoffzufuhr. 1. Auflage, Umschau/Braus Verlag, Frankfurt am Main.

Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung: Referenzwerte für die Nährstoffzufuhr. 1. Auflage, 5., korrigierter Nachdruck, Neuer Umschau Buchverlag, Neustadt an der Weinstraße, 2013.

Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung: Referenzwerte für die Nährstoffzufuhr. Verfügbar unter: https://www.dge.de/wissenschaft/referenzwerte/(eingesehen am 07.07.2021)

Dietl H., Ohlenschläger G. (2003) Handbuch der Orthomolekularen Medizin. Karl F. Haug Verlag, Stuttgart

Domke A, Großklaus R, Niemann B, Przyrembel H, Richter K, Schmidt E, Weißenborn A, Wörner B, Ziegenhagen R: Verwendung von Mineralstoffen in Lebensmitteln. Toxikologische und ernährungsphysiologische Aspekte Teil II Bundesinstitut für Risikobewertung. Verfügbar unter: http://www.bfr.bund.de/cm/350/verwendung_von_mineralstoffen_in_lebensmitteln_bfr_wissenschaft_4_2004.pdf (eingesehen am 28.06.2022)

Einkaufs-und Ernährungsverhalten in Deutschland TNS-Emnid-Umfrage des Bundesministerium für Ernährung und Landwirtschaft, BMEL, (2014). Verfügbar unter: https://www.bmel.de/SharedDocs/Downloads/DE/_Ernaehrung/Lebensmittel-Kennzeichnung/TNS-Emnid-EinkaufsErnaehrungsVerhaltenInDeutschland.pdf?__blob=publicationFile&v=2 (eingesehen am 28.06.2022)

Europäische Richtlinie (2008/100/EG) vom 28. Oktober 2008 über die Nährwertkennzeichnung von Lebensmitteln hinsichtlich der empfohlenen Tagesdosen, der Umrechnungsfaktoren für den Energiewert und der Definitionen online verfügbar unter: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32008L0100:DE:HTML (eingesehen am 28.06.2022)

Europäische Empfehlungen: European Micronutrient Recommendations Aligned (EURRECA). Verfügbar unter: http://www.eufic.org/en/collaboration/article/european-micronutrient-recommendations-aligned (eingesehen am 28.06.2022)

Food and Nutrtition Information Center der US Regierung (DRI-Empfehlungen). Verfügbar unter: https://www.nal.usda.gov/fnic/dri-nutrient-reports (eingesehen am 28.06.2022)

Food Standards Agency (2002) Expert Group on Vitamins and Minerals. Review of Molybdenum.

Food Standards Agency (2003) Safe Upper Levels for Vitamins and Minerals. Expert Group on Vitamins and Minerals, May 2003

Gröber U: Orthomolekulare Medizin. Ein Leitfaden für Apotheker und Ärzte. 3. Auflage. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart 2008

Heppe F, Wigand M: Lexikon Diätetische Indikationen. Spezielle Ernährungstherapie und Ernährungsprävention. 4. Auflage. Springer 2002

Hernandez Ramos F: Antienvejecimiento con nutrición ortomolecular. Integral 2007

Institute of Medicine: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academy Press, Washington, 2001

Koula-Jenik H, Kraft M, Miko M, Schulz RJ: Leitfaden Ernährungsmedizin. Urban & Fischer 2006

Otten JJ, Pitzi-Hellwig J, Meyers L (Eds): Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. The National Academies Press, Washington DC 2006

Richtlinie der European Food Safety Authority, EFSA, mit dem Titel „Scientific Committee on Food, Scientific Panel on Dietetic Products, Nutrition and Allergies: tolerable Upper Intake Levels for Vitamins and minerals. February 2006“.

Subcommittee on the Tenth Edition of the RDAs, Food and Nutrition Board, Commission on Life Sciences, National Research Council: Recommended Dietary Allowances: 10th Edition. National Academy Press, Washington DC, 1989.

Vollwertig essen und trinken nach den 10 Regeln der DGE verfügbar unter: http://www.dge.de/modules.php?name=Content&pa=showpage&pid=15 (eingesehen am 28.06.2022)

Pharmabrain Logo

European Union Trademark no. 006894216
US Patent and Trademark Office reg. no. 3,705,613
International Registration 1460744
All rights reserved.

Wir sind Pharmabrain.

Pharmabrain GmbH – Wir trainieren Ihren Erfolg
Gesundheitskommunikation, Teamentwicklung, Projektmanagement

Kontakt

Pharmabrain GmbH
Telefon: +49-30-28091515
E-Mail: support@pharmabrain.org

Research and Training Center

Schumannstr. 7b
D-10117 Berlin

Verwaltung

Schumannstr. 7a
D-10117 Berlin